Literature DB >> 12831997

Neuromorphological background of cannabis addiction.

Tibor Wenger1, Gabriella Moldrich, Susanna Furst.   

Abstract

The expression of central cannabinoid (CB1) receptors in tyrosine hydroxylase (TH) containing neurones was demonstrated. Co-localisation was present in different brain areas responsible for reward-related mechanisms. The immunohistochemical investigations have shown that co-localisation is present in parts of mesolimbic-mesocortical dopaminergic system like nucleus accumbens (Nacb), ventral tegmental area (VTA), in the striatum, pyriform cortex, respectively. The results suggest a functional role of CB1 receptors in cannabis addiction by acting directly on reward-related structures.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12831997     DOI： 10.1016/s0361-9230(03)00081-9

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN： 0361-9230            Impact factor:   4.077


  22 in total

1.  Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse.

Authors:  Salvatore Lecca; Miriam Melis; Antonio Luchicchi; Anna Lisa Muntoni; Marco Pistis
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

Review 2.  Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective.

Authors:  Dragan M Svrakic; Patrick J Lustman; Ashok Mallya; Taylor Andrea Lynn; Rhonda Finney; Neda M Svrakic
Journal:  Mo Med       Date:  2012 Mar-Apr

3.  Viral-mediated knockdown of mGluR7 in the nucleus accumbens mediates excessive alcohol drinking and increased ethanol-elicited conditioned place preference in rats.

Authors:  Amine Bahi
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

4.  Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro.

Authors:  Sang R Kim; Da Y Lee; Eun S Chung; Uh T Oh; Seung U Kim; Byung K Jin
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

Review 5.  Cannabis cue-elicited craving and the reward neurocircuitry.

Authors:  Francesca M Filbey; Samuel J DeWitt
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-11-09       Impact factor: 5.067

6.  Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels.

Authors:  Zsuzsanna Sidló; Patricia H Reggio; Margaret E Rice
Journal:  Neurochem Int       Date:  2007-07-22       Impact factor: 3.921

Review 7.  Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate.

Authors:  K Rea; M Roche; D P Finn
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

8.  Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users.

Authors:  Daniel S Albrecht; Patrick D Skosnik; Jennifer M Vollmer; Margaret S Brumbaugh; Kevin M Perry; Bruce H Mock; Qi-Huang Zheng; Lauren A Federici; Elizabeth A Patton; Christine M Herring; Karmen K Yoder
Journal:  Drug Alcohol Depend       Date:  2012-08-19       Impact factor: 4.492

9.  Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior.

Authors:  K S Sink; V K Vemuri; T Olszewska; A Makriyannis; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2007-11-15       Impact factor: 4.530

10.  Methanandamide blocks amphetamine-induced behavioral sensitization in rats.

Authors:  Bruce A Rasmussen; Ellen M Unterwald; Jae K Kim; Scott M Rawls
Journal:  Eur J Pharmacol       Date:  2009-10-30       Impact factor: 4.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.